These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1669041)

  • 1. A study of gentamicin nephrotoxicity by examining the creatinine clearance and beta 2-microglobulin before and after antibiotic course of treatment.
    Dimitrakov D; Despotov T; Kumchev E; Deenichina S; Stankova G; Tsvetkova Z
    Folia Med (Plovdiv); 1991; 33(4):40-2. PubMed ID: 1669041
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics and nephrotoxicity of continuous intravenous infusion of gentamicin in low birth weight infants.
    Giacoia GP; Schentag JJ
    J Pediatr; 1986 Oct; 109(4):715-9. PubMed ID: 3531452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The absence of nephrotoxicity and differential nephrotoxicity between tobramycin and gentamicin.
    Kepczyk T; Ryan PJ; McAllister K; Otraje J
    South Med J; 1990 Oct; 83(10):1149-52. PubMed ID: 2218653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amylase-creatinine clearance ratio. A simple test to predict gentamicin nephrotoxicity.
    Aderka D; Tene M; Graff E; Levo Y
    Arch Intern Med; 1988 May; 148(5):1093-6. PubMed ID: 2452611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycoside nephrotoxicity: a double blind prospective randomized study of gentamicin and tobramycin.
    Feig PU; Mitchell PP; Abrutyn E; Brock SM; Carney WR; Graeber CW; Horak E; Lyons RW; Maher JF
    J Antimicrob Chemother; 1982 Sep; 10(3):217-26. PubMed ID: 6754682
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship between the renal clearance of creatinine and the apparent renal clearance of beta-2-microglobulin in patients with normal and impaired kidney function.
    Vree TB; Guelen PJ; Jongman-Nix B; Walenkamp GH
    Clin Chim Acta; 1981 Jul; 114(1):93-9. PubMed ID: 6166414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal handling of beta-2-microglobulin in neonates treated with gentamicin.
    Assadi FK; Chow-Tung E
    Nephron; 1988; 49(2):114-8. PubMed ID: 3288887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of a change in gentamicin clearance as an early predictor of gentamicin-induced nephrotoxicity.
    Kirkpatrick CM; Duffull SB; Begg EJ; Frampton C
    Ther Drug Monit; 2003 Oct; 25(5):623-30. PubMed ID: 14508386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Can piperacillin modify the experimental nephrotoxicity of gentamicin?].
    Thomas N; Toutain H; Dadoun C; Morin JP; Fillastre JP
    Presse Med; 1986 Dec; 15(46):2362-7. PubMed ID: 2949288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of N-acetyl-glucosaminidase and beta-2-microglobulin as early markers of gentamicin nephrotoxicity in neonates.
    Gouyon JB; Aujard Y; Abisror A; Laudignon N; d'Athis P; Jacqz E; Biou D; Demelier JF; Mathieu H
    Dev Pharmacol Ther; 1987; 10(2):145-52. PubMed ID: 3301233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gentamicin disposition and effect on development of renal function in the very low birth weight infant.
    Landers S; Berry PL; Kearns GL; Kaplan SL; Rudolph AJ
    Dev Pharmacol Ther; 1984; 7(5):285-302. PubMed ID: 6383749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of beta-2 microglobulinuria associated with gentamicin therapy.
    Kaye WA; Griffiths WC; Camara PD; Trebbin WM; Solomon RJ; Diamond I
    Ann Clin Lab Sci; 1981; 11(6):530-7. PubMed ID: 6173009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of hydroxytyrosol on gentamicin induced nephrotoxicity in mice.
    Chashmi NA; Emadi S; Khastar H
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1427-1429. PubMed ID: 27965098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with creatinine clearance changes following gentamicin therapy.
    Prince RA; Ling MH; Hepler CD; Rainville EC; Kealey GP; Donta ST; LeFrock JL; Kowalsky SF
    Am J Hosp Pharm; 1980 Nov; 37(11):1489-95. PubMed ID: 7211851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agmatine improves renal function in gentamicin-induced nephrotoxicity in rats.
    El-Kashef DH; El-Kenawi AE; Abdel Rahim M; Suddek GM; Salem HA
    Can J Physiol Pharmacol; 2016 Mar; 94(3):278-86. PubMed ID: 26641937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary alanine aminopeptidase and beta 2-microglobulin as measurements of aminoglycoside-associated renal impairment.
    Trollfors B; Bergmark J; Hiesche K; Jagenburg R
    Infection; 1984; 12(1):20-2. PubMed ID: 6142864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary beta 2-microglobulin: early indicator of high dose cisdiamminedichloroplatinum nephrotoxicity? Influence of furosemide.
    de Gislain C; Dumas M; d'Athis P; Lautissier JL; Escousse A; Guerrin J
    Cancer Chemother Pharmacol; 1986; 18(3):276-9. PubMed ID: 3542269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cisplatin-induced nephrotoxicity on gentamicin pharmacokinetics in rats.
    Engineer MS; Bodey GP; Newman RA; Ho DH
    Drug Metab Dispos; 1987; 15(3):329-34. PubMed ID: 2886307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-2-microglobulin excretion in neonates treated with gentamicin.
    Arellano F
    Nephron; 1989; 53(4):392-3. PubMed ID: 2689902
    [No Abstract]   [Full Text] [Related]  

  • 20. Carvedilol: a beta blocker with antioxidant property protects against gentamicin-induced nephrotoxicity in rats.
    Kumar KV; Shifow AA; Naidu MU; Ratnakar KS
    Life Sci; 2000 May; 66(26):2603-11. PubMed ID: 10883738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.